• Immunity helping scientists develop malaria vaccine
    Immunity helping scientists develop malaria vaccine

Bioanalytical

Immunity helping scientists develop malaria vaccine

May 23 2014

US researchers may have found a breakthrough when it comes to developing a cure for malaria. The team are working with a group of children in Tanzania who are naturally immune to the disease in the hope of developing a vaccine.

The research, published in the journal Science, found the children are able to produce an antibody, which then attacks the malaria-causing parasite. The team then discovered that injecting a form of this antibody into mice protected them from the disease.

Professor Jake Kurtis, director of the Center for International Health Research at Rhode Island Hospital, Brown University School of Medicine, said there was "compelling evidence" but further trials were needed in primates and humans to comprehensively assess the vaccine.

Calling the research "a bona fide vaccine candidate", he added that the parasite was particularly difficult to attack, as a result of its millions of years of evolution to co-opt and adapt to our immune responses. 

According to the World Health Organization (WHO), the disease killed more than 600,000 people in 2012, with 90 per cent of these deaths occurring in sub-Saharan Africa and the majority of them being children under five.

For the study, some 1,000 children in Tanzania had regular blood samples taken in the first years of their lives, which found that six per cent developed a naturally-acquired immunity to malaria. This was despite them living in an area that has a high concentration of the disease.

The team found that the immune children were able to produce an antibody to attack the malaria parasite at a key stage of its life-cycle. This restricts the small organism by surrounding it in red blood cells, which stops it from spreading to the rest of the body.

When the team made this antibody into an injection for small groups of mice, they found that it showed potential for a new vaccine.

Professor Kurtis said: "The survival rate was over two-fold longer if the mice were vaccinated compared to unvaccinated - and the parasitemia (the number of parasites in the blood) were up to four-fold lower in the vaccinated mice."


Digital Edition

Chromatography Today - Buyers' Guide 2022

October 2023

In This Edition Modern & Practical Applications - Accelerating ADC Development with Mass Spectrometry - Implementing High-Resolution Ion Mobility into Peptide Mapping Workflows Chromatogr...

View all digital editions

Events

EuCheMS Chemistry Congress

Jul 07 2024 Dublin, Ireland

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA

JASIS 2024

Sep 04 2024 Chiba, Tokyo, Japan

View all events